Magnetic Resonance Imaging (MRI) in Asymptomatic Patients With Juvenile Idiopathic Arthritis (JIA)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00800371
Recruitment Status : Unknown
Verified November 2008 by University Hospital Tuebingen.
Recruitment status was:  Recruiting
First Posted : December 2, 2008
Last Update Posted : December 2, 2008
Information provided by:
University Hospital Tuebingen

Brief Summary:

Juvenile idiopathic arthritis (JIA) may progress asymptomatically leading to joint destruction despite treatment.

The aim of the observational study is to describe patients with silent arthritis comparing symptoms, clinical findings with results of ultrasound and magnetic resonance imaging (MRI).

Condition or disease Intervention/treatment
Juvenile Idiopathic Arthritis Procedure: intra-articular steroid injection

Study Type : Observational
Estimated Enrollment : 20 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Diagnostic Value of MRI and Ultrasound in Patients With JIA
Study Start Date : May 2008
Estimated Primary Completion Date : December 2009
Estimated Study Completion Date : June 2010

Resource links provided by the National Library of Medicine

U.S. FDA Resources

Group/Cohort Intervention/treatment
Patients with JIA
Procedure: intra-articular steroid injection
Steroid injection into otherwise noncontrollable arthritis.

Primary Outcome Measures :
  1. Definition of patients with silent arthritis. [ Time Frame: every three to six months from recruitment to end of study ]

Secondary Outcome Measures :
  1. Comparison of diagnostic value of MRI and ultrasound. [ Time Frame: every three to six months from recruitment to end of study ]

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   7 Years to 17 Years   (Child)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
Patients with JIA

Inclusion Criteria:

  • children without symptoms or with only mild joints swelling or with only minimal limited range of motion

Exclusion Criteria:

  • patients with manifest arthritis

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT00800371

Contact: Nikolay Tzaribachev, MD +49707129 ext 84711

University Children's Hospital Recruiting
Tuebingen, Baden-Wuerttemberg, Germany, 72076
Principal Investigator: Nikolay Tzaribachev, MD         
Sponsors and Collaborators
University Hospital Tuebingen
Principal Investigator: Nikolay Tzaribachev, MD University Hospital Tuebingen

Responsible Party: Nikolay Tzaribachev, MD, University Children's Hospital Identifier: NCT00800371     History of Changes
Other Study ID Numbers: Silent Arthritis PROSPECT 2008
First Posted: December 2, 2008    Key Record Dates
Last Update Posted: December 2, 2008
Last Verified: November 2008

Keywords provided by University Hospital Tuebingen:

Additional relevant MeSH terms:
Arthritis, Juvenile
Joint Diseases
Musculoskeletal Diseases
Rheumatic Diseases
Connective Tissue Diseases
Autoimmune Diseases
Immune System Diseases